Dichotomous effects of VEGF-A on adipose tissue dysfunction

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 15, 2012, Pages 5874-5879

  Sun, Kai ^a   Asterholm, Ingrid Wernstedt ^a   Kusminski, Christine M ^a   Bueno, Ana Carolina ^a,b   Wang, Zhao V ^a   Pollard, Jeffrey W ^c   Brekken, Rolf A ^a   Scherer, Philipp E ^a,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Hypoxia; Neovascularization; Obesity; VEGF receptor 2

Indexed keywords

DOXYCYCLINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; UNCOUPLING PROTEIN 1; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENERGY EXPENDITURE; INHIBITION KINETICS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE EXPANSION; UPREGULATION; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; ANGIOGENESIS INHIBITORS; ANIMALS; CELL HYPOXIA; CELL SIZE; DIETARY FATS; ENERGY METABOLISM; FATTY LIVER; FIBROSIS; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MICE; MICE, INBRED C57BL; MICE, OBESE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SPECIFICITY; PHENOTYPE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; WEIGHT GAIN;

MUS;

EID: 84859615812     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1200447109     Document Type: Article

References (24)

1. Rosen ED, MacDougald OA (2006) Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7:885-896. (Pubitemid 44871415)
2. Sethi JK, Vidal-Puig AJ (2007) Thematic review series: Adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 48:1253-1262. (Pubitemid 47312027)
3. Sun K, Kusminski CM, Scherer PE (2011) Adipose tissue remodeling and obesity. J Clin Invest 121:2094-2101.
4. Cao Y (2010) Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov 9:107-115.
5. Zhang QX, et al. (1997) Vascular endothelial growth factor is the major angiogenic factor in omentum:Mechanismof the omentum-mediated angiogenesis. J SurgRes 67:147-154.
6. Hausman GJ, Richardson RL (2004) Adipose tissue angiogenesis. J AnimSci 82:925-934. (Pubitemid 38572359)
7. Tam J, et al. (2009) Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: Role of local versus bone marrow-derived endothelial cells. PLoS ONE 4:e4974.
8. Liekens S, De Clercq E, Neyts J (2001) Angiogenesis: Regulators and clinical applications. Biochem Pharmacol 61:253-270. (Pubitemid 32126663)
9. Zwetsloot KA, Westerkamp LM, Holmes BF, Gavin TP (2008) AMPK regulates basal skeletal muscle capillarization and VEGF expression, but is not necessary for the angiogenic response to exercise. J Physiol 586:6021-6035.
10. Halberg N, et al. (2009) Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 29:4467-4483.
11. Daquinag AC, Zhang Y, Kolonin MG (2011) Vascular targeting of adipose tissue as an anti-obesity approach. Trends Pharmacol Sci 32:300-307.
12. Rupnick MA, et al. (2002) Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99:10730-10735.
13. Kajimura S, et al. (2008) Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev 22:1397-1409. (Pubitemid 351717529)
14. Lin EY, et al. (2007) Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages. Mol Oncol 1:288-302. (Pubitemid 350181649)
15. Wang ZV, Deng Y, Wang QA, Sun K, Scherer PE (2010) Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression. Endocrinology 151:2933-2939.
16. Sato Y, et al. (2000) Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann N Y Acad Sci 902:201-205, discussion 205-207.
17. Xue Y, et al. (2009) Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab 9:99-109.
18. Sullivan LA, et al. (2010) r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction. PLoS ONE 5:e12031.
19. Cannon B, Nedergaard J (2004) Brown adipose tissue: Function and physiological significance. Physiol Rev 84:277-359. (Pubitemid 38054374)
20. Unger RH, Clark GO, Scherer PE, Orci L (2010) Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 1801:209-214.
21. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W (2004) Reversal of obesity by targeted ablation of adipose tissue. Nat Med 10:625-632. (Pubitemid 38796854)
22. Dallabrida SM, Rupnick MA (2002) Vascular endothelium in tissue remodeling: Implications for heart failure. Cold Spring Harb Symp Quant Biol 67:417-427. (Pubitemid 36775538)
23. Bråkenhielm E, et al. (2004) Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 94:1579-1588. (Pubitemid 38856965)
24. Hosogai N, et al. (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56:901-911 (Pubitemid 46525054)